Concord Wealth Partners Viatris Inc Transaction History

Concord Wealth Partners

$591 Million
Q3 2024

A detailed history of Concord Wealth Partners transactions in Viatris Inc stock. As of the latest transaction made, Concord Wealth Partners holds 2,726 shares of VTRS stock, worth $35,438. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,726

Previous 2,258 20.73%

Holding current value

$35,438

Previous $24,000 29.17%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$10.32 - $12.13 $4,829 - $5,676	468 Added 20.73%	2,726 $31,000
Q2 2024 Jul 31, 2024	BUY	$10.05 - $12.02 $70 - $84	7 Added 0.31%	2,258 $24,000
Q1 2024 Apr 30, 2024	SELL	$11.27 - $13.53 $416 - $500	-37 Reduced 1.62%	2,251 $26,000
Q3 2023 Oct 25, 2023	BUY	$9.59 - $11.35 $19,947 - $23,608	2,080 Added 1000.0%	2,288 $22,000
Q2 2023 Aug 07, 2023	SELL	$9.02 - $10.29 $18,301 - $20,878	-2,029 Reduced 90.7%	208 $2,000
Q1 2023 Apr 26, 2023	BUY	$9.2 - $12.26 $4,563 - $6,080	496 Added 28.49%	2,237 $21,000
Q4 2022 Jan 27, 2023	BUY	$8.72 - $11.56 $15,181 - $20,125	1,741 New	1,741 $19,000
Q2 2022 Aug 04, 2022	SELL	$9.95 - $12.27 $8,845 - $10,908	-889 Reduced 32.3%	1,863 $20,000
Q1 2022 Apr 20, 2022	SELL	$9.81 - $15.4 $4,473 - $7,022	-456 Reduced 14.21%	2,752 $30,000
Q4 2021 Jan 21, 2022	BUY	$12.09 - $14.68 $37,176 - $45,141	3,075 Added 2312.03%	3,208 $43,000
Q3 2021 Nov 09, 2021	SELL	$13.25 - $15.13 $16,734 - $19,109	-1,263 Reduced 90.47%	133 $2,000
Q2 2021 Jul 29, 2021	SELL	$12.97 - $16.15 $804 - $1,001	-62 Reduced 4.25%	1,396 $20,000
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $12,312 - $16,797	906 Added 164.13%	1,458 $20,000
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $7,893 - $10,344	552 New	552 $10,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Account

Concord Wealth Partners Viatris Inc Transaction History